EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume -, Issue -, Pages annrheumdis-2021-221733
Publisher
BMJ
Online
2022-02-03
DOI
10.1136/annrheumdis-2021-221733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial
- (2021) Lotta Ulander et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The changing landscape of atherosclerosis
- (2021) Peter Libby NATURE
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis
- (2021) Mehrdad Maz et al. Arthritis & Rheumatology
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2021) Liana Fraenkel et al. Arthritis & Rheumatology
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study
- (2020) Evrydiki Kravvariti et al. AUTOIMMUNITY REVIEWS
- Predictors of fatal and non-fatal cardiovascular events in ANCA-associated vasculitis: Data from the Toronto CanVasc cohort
- (2020) Eline Houben et al. JOINT BONE SPINE
- 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
- (2020) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus
- (2020) Konstantinos Tselios et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiovascular Risk Factors and Atherosclerotic Cardiovascular Events Among Incident Cases of Systemic Sclerosis: Results From a Population-Based Cohort (1980-2016)
- (2020) Reto D. Kurmann et al. MAYO CLINIC PROCEEDINGS
- Targeting Inflammation to Reduce Residual Cardiovascular Risk
- (2020) Oluremi N. Ajala et al. Current Atherosclerosis Reports
- Systemic sclerosis and risk of cardiovascular disease
- (2020) Xintao Cen et al. MEDICINE
- C-REACTIVE PROTEIN LEVELS MODULATE LIPOPROTEIN(A)-ASSOCIATED CARDIOVASCULAR RISK IN OPTIMALLY-TREATED PATIENTS WITH HIGH-RISK VASCULAR DISEASE
- (2019) Rishi Puri et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ischemic stroke in giant-cell arteritis: French retrospective study
- (2019) Aaron Pariente et al. JOURNAL OF AUTOIMMUNITY
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. CIRCULATION
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study
- (2019) Iris J. M. Disveld et al. CLINICAL RHEUMATOLOGY
- Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis
- (2019) Hubert de Boysson et al. JOURNAL OF AUTOIMMUNITY
- Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
- (2019) Eun Ha Kang et al. RHEUMATOLOGY
- The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
- (2019) Massimo Radin et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- 2018 Update of the EULAR recommendations for the management of large vessel vasculitis
- (2019) Bernhard Hellmich et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of Statins as Primary Prevention in People With Gout: A Population-Based Cohort Study
- (2019) Maria Garcia-Gil et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Blood Pressure Variability and Age-related Blood Pressure Patterns in Systemic Lupus Erythematosus
- (2019) George Stojan et al. JOURNAL OF RHEUMATOLOGY
- Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitis
- (2019) Eline Houben et al. RHEUMATOLOGY
- Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study
- (2019) Gabriele Valentini et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
- (2019) Manuel Ramos-Casals et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study
- (2018) MaryAnn Zhang et al. CIRCULATION
- Atherosclerosis and inflammation: overview and updates
- (2018) Glaucylara Reis Geovanini et al. CLINICAL SCIENCE
- Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study
- (2018) Alvise Berti et al. MAYO CLINIC PROCEEDINGS
- The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts
- (2018) Serena Fasano et al. MEDICINE
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
- (2018) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980–2011)
- (2018) Achille Aouba et al. RHEUMATOLOGY
- Statin use and mortality in gout: A general population-based cohort study
- (2018) Sarah F. Keller et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis
- (2018) Yi-Hua Bai et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody Positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Reposi
- (2018) Ozan Unlu et al. ARTHRITIS CARE & RESEARCH
- Cerebrovascular Events in Systemic Lupus Erythematosus
- (2018) John G. Hanly et al. ARTHRITIS CARE & RESEARCH
- Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study
- (2018) Ioana Ruiz-Arruza et al. ARTHRITIS CARE & RESEARCH
- Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
- (2018) Bryant R England et al. BMJ-British Medical Journal
- Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
- (2018) Bryant R England et al. BMJ-British Medical Journal
- The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies
- (2018) Matteo Nicola Dario Di Minno et al. ATHEROSCLEROSIS
- Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
- (2018) Serena Fasano et al. CLINICAL RHEUMATOLOGY
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. EUROPEAN HEART JOURNAL
- Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study
- (2017) Hsiu-Chen Lin et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout
- (2017) Margaret Noyes Essex et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study
- (2017) Konstantinos Tselios et al. JOURNAL OF RHEUMATOLOGY
- Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study
- (2017) Hung-Lin Chen et al. JOURNAL OF RHEUMATOLOGY
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies
- (2017) Eline Houben et al. RHEUMATOLOGY
- Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study
- (2017) Chung-Yuan Hsu et al. RHEUMATOLOGY
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
- (2017) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
- (2017) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
- (2016) R Agca et al. ANNALS OF THE RHEUMATIC DISEASES
- 2016 updated EULAR evidence-based recommendations for the management of gout
- (2016) P Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus
- (2016) M. B. Urowitz et al. JOURNAL OF RHEUMATOLOGY
- Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study
- (2016) G. Pugnet et al. JOURNAL OF RHEUMATOLOGY
- Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus
- (2016) A. Hinojosa-Azaola et al. JOURNAL OF RHEUMATOLOGY
- Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study
- (2016) Michele Iudici et al. RHEUMATOLOGY
- Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study
- (2016) Konstantinos Tselios et al. ARTHRITIS CARE & RESEARCH
- Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012
- (2016) Maria G. Tektonidou et al. Arthritis & Rheumatology
- The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors
- (2016) Francis J. Alenghat Scientific Reports
- Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study
- (2015) Hsin-Hui Yu et al. ATHEROSCLEROSIS
- Cardiovascular Events in Systemic Lupus Erythematosus
- (2015) Antonio Fernández-Nebro et al. MEDICINE
- Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study
- (2015) Jiunn-Horng Chen et al. PLoS One
- 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
- (2014) Désirée van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink
- (2014) Lorna E Clarson et al. ANNALS OF THE RHEUMATIC DISEASES
- Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
- (2014) R Cervera et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevention of Comorbidity and Acute Attack of Gout by Uric Acid Lowering Therapy
- (2014) Kowoon Joo et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Factors Associated with Major Cardiovascular Events in Patients with Systemic Necrotizing Vasculitides: Results of a Longterm Followup Study
- (2014) B. Terrier et al. JOURNAL OF RHEUMATOLOGY
- Allopurinol Therapy in Gout Patients Does Not Associate with Beneficial Cardiovascular Outcomes: A Population-Based Matched-Cohort Study
- (2014) Victor C. Kok et al. PLoS One
- Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis
- (2014) Flavia Ballocca et al. European Journal of Preventive Cardiology
- Relation of Carotid Intima-Media Thickness and Plaque With Incident Cardiovascular Events in Women With Systemic Lupus Erythematosus
- (2013) Amy H. Kao et al. AMERICAN JOURNAL OF CARDIOLOGY
- Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials
- (2013) Joanna Robson et al. ANNALS OF THE RHEUMATIC DISEASES
- Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout
- (2013) Fernando Perez-Ruiz et al. ANNALS OF THE RHEUMATIC DISEASES
- Assessment of Coronary Risk Based on Cumulative Exposure to Lipids in Systemic Lupus Erythematosus
- (2013) M. Nikpour et al. JOURNAL OF RHEUMATOLOGY
- Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality
- (2013) A.G. Stack et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis
- (2013) LE Clarson et al. European Journal of Preventive Cardiology
- Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
- (2012) L. S. Magder et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden
- (2012) Bengt Zöller et al. BMC Neurology
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Subsequent Coronary Heart Disease in Patients Hospitalized for Immune-Mediated Diseases: A Nationwide Follow-Up Study from Sweden
- (2012) Bengt Zöller et al. PLoS One
- Risk of myocardial infarction among patients with gout: a nationwide population-based study
- (2012) C.-F. Kuo et al. RHEUMATOLOGY
- Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study
- (2012) Johanna T Gustafsson et al. ARTHRITIS RESEARCH & THERAPY
- A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis
- (2011) Ravi Suppiah et al. ARTHRITIS CARE & RESEARCH
- Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study
- (2011) Mandana Nikpour et al. ARTHRITIS RESEARCH & THERAPY
- AGREE II: advancing guideline development, reporting and evaluation in health care
- (2010) M. C. Brouwers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Colchicine poisoning: the dark side of an ancient drug
- (2010) Yaron Finkelstein et al. CLINICAL TOXICOLOGY
- Risk Factors for Development of Coronary Artery Disease in Women with Systemic Lupus Erythematosus
- (2009) R. J. GOLDBERG et al. JOURNAL OF RHEUMATOLOGY
- Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus
- (2009) A Becker-Merok et al. LUPUS
- Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort
- (2009) G. J. Pons-Estel et al. RHEUMATOLOGY
- The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI)
- (2009) A. J. Mohammad et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study
- (2009) Johanna Gustafsson et al. ARTHRITIS RESEARCH & THERAPY
- EULAR recommendations for the management of large vessel vasculitis
- (2008) C Mukhtyar et al. ANNALS OF THE RHEUMATIC DISEASES
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started